Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?

Introduction: Based on the existing literature, omalizumab (OMZ) is considered a safe treatment modality in chronic spontaneous urticaria (CSU) during the coronavirus disease 19 (COVID-19) era.  Objectives: The aim of this study is to evaluate the effects of OMZ on CSU patients regarding COVID-19 in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Özge Kaya (Verfasst von), Zeynep Keskinkaya (Verfasst von), Selda Işık Mermutlu (Verfasst von), Sevilay Oğuz Kılıç (Verfasst von), Sevgi Öztürk (Verfasst von)
Format: Buch
Veröffentlicht: Mattioli1885, 2023-07-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Online

Connect to this object online.

3rd Floor Main Library

Bestandsangaben von 3rd Floor Main Library
Signatur: A1234.567
Exemplar 1 Verfügbar